Loading organizations...
Loading organizations...
Developing small molecule bromodomain inhibitors for cancer treatment.
Tensha Therapeutics has raised $15.0M across 1 funding round.
Tensha Therapeutics has raised $15.0M in total across 1 funding round.
Tensha Therapeutics has raised $15.0M in total across 1 funding round.
Tensha Therapeutics's investors include Douglas E. Onsi.
Tensha Therapeutics has raised $15.0M across 1 funding round. Most recently, it raised $15.0M Series A in September 2011.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 12, 2011 | $15.0M Series A | Douglas E. Onsi |